CLIP-LUX: A luminescent split-ubiquitin assay using ClpS-mediated N-degron recognition for detection of protein-protein interactions in mammalian cells
Disease and Therapeutics · 2026 · 2 · 100005
DOI: 10.1016/j.dist.2026.100005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease and Therapeutics, 2026. Verfasst von Jiyoon Kim und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, University of Toronto, Barrett Foundation.
Abstract (Originalsprache)
Protein-protein interactions (PPIs) are central to virtually all cellular processes and serve as critical nodes for drug discovery. Here, we present a next-generation luminescent hybrid assay, termed CLIP-LUX, that integrates the split ubiquitin system with ClpS-mediated N-degron recognition to enable rapid, sensitive, and quantitative detection of PPIs in living mammalian cells. Existing methods for studying PPIs in mammalian cells often face a trade-off between sensitivity and temporal resolution: transcription-based assays provide strong signal amplification but slow kinetics, whereas luminescence complementation assays offer rapid readouts but limited amplification. CLIP-LUX overcomes these limitations by coupling split-ubiquitin processing to bacterial ClpS-N-degron recognition, thereby producing a luminescent signal directly upon protein interaction. In this design, ubiquitin reassembly triggered by PPIs induces cleavage of a phenylalanine-SmBiT degron probe, which is then recognized by LgBiT-ClpS to reconstitute NanoLuc activity. This configuration eliminates background activation, bypasses the need for transcriptional amplification, and preserves signal accumulation through ubiquitin processing. CLIP-LUX effectively detects PPIs involving both membrane and cytosolic proteins, distinguishes mutant-specific and ligand-dependent PPIs, and captures the effects of small molecule inhibitors and PROTACs. By decoupling PPI detection from transcription while maintaining signal amplification, this ClpS-coupled hybrid platform provides a robust, versatile and high-sensitivity approach for dynamic PPI analysis and high-throughput drug screening in mammalian cells.
Förderung
- Canadian Institutes of Health Research
- University of Toronto
- Barrett Foundation
Zitieren
APA
Kim, J., Snider, J., & Stagljar, I. (2026). CLIP-LUX: A luminescent split-ubiquitin assay using ClpS-mediated N-degron recognition for detection of protein-protein interactions in mammalian cells. Disease and Therapeutics, 2, 100005. https://doi.org/10.1016/j.dist.2026.100005
Vancouver
Kim J, Snider J, Stagljar I. CLIP-LUX: A luminescent split-ubiquitin assay using ClpS-mediated N-degron recognition for detection of protein-protein interactions in mammalian cells. Disease and Therapeutics. 2026;2:100005. doi:10.1016/j.dist.2026.100005
BibTeX
@article{Kim2026,
author = {Kim, Jiyoon and Snider, Jamie and Stagljar, Igor},
title = {CLIP-LUX: A luminescent split-ubiquitin assay using ClpS-mediated N-degron recognition for detection of protein-protein interactions in mammalian cells},
journal = {Disease and Therapeutics},
year = {2026},
volume = {2},
pages = {100005},
doi = {10.1016/j.dist.2026.100005}
}
EUVIMED